Literature DB >> 21679854

Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.

Evren Caglayan1, Marius Vantler, Olli Leppänen, Felix Gerhardt, Lenard Mustafov, Henrik Ten Freyhaus, Kai Kappert, Margarete Odenthal, Wolfram H Zimmermann, Michelle D Tallquist, Stephan Rosenkranz.   

Abstract

OBJECTIVES: We tested the hypothesis whether selective blunting of platelet-derived growth factor (PDGF)-dependent vascular smooth muscle cell (VSMC) proliferation and migration is sufficient to prevent neointima formation after vascular injury.
BACKGROUND: To prevent neointima formation and stent thrombosis after coronary interventions, it is essential to inhibit VSMC proliferation and migration without harming endothelial cell function. The role of PDGF-a potent mitogen and chemoattractant for VSMC that does not affect endothelial cells-for neointima formation remains controversial.
METHODS: To decipher the signaling pathways that control PDGF beta receptor (βPDGFR)-driven VSMC proliferation and migration, we characterized 2 panels of chimeric CSF1RPDGFR mutants in which the binding sites for βPDGFR-associated signaling molecules (Src, phosphatidylinositol 3-kinase [PI3K], GTPase activating protein of ras, SHP-2, phospholipase Cγ 1 [PLCγ]) were individually mutated. Based on in vitro results, the importance of PDGF-initiated signals for neointima formation was investigated in genetically modified mice.
RESULTS: Our results indicate that the chemotactic response to PDGF requires the activation of Src, PI3K, and PLCγ, whereas PDGF-dependent cell cycle progression is exclusively mediated by PI3K and PLCγ. These 2 signaling molecules contribute to signal relay of the βPDGFR by differentially regulating cyclin D1 and p27(kip1). Blunting of βPDGFR-induced PI3K and PLCγ signaling by a combination mutant (F3) completely abolished the mitogenic and chemotactic response to PDGF. Disruption of PDGF-dependent PI3K and PLCγ signaling in mice expressing the F3 receptor led to a profound reduction of neointima formation after balloon injury.
CONCLUSIONS: Signaling by the activated βPDGFR, particularly through PI3K and PLCγ, is crucial for neointima formation after vascular injury. Disruption of these specific signaling pathways is sufficient to attenuate pathogenic processes such as vascular remodeling in vivo.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679854      PMCID: PMC3732311          DOI: 10.1016/j.jacc.2011.02.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice.

Authors:  Christian M Matter; Liming Ma; Tobias von Lukowicz; Patricia Meier; Christine Lohmann; Dongming Zhang; Ulkan Kilic; Eugen Hofmann; Suk-Woo Ha; Martin Hersberger; Dirk M Hermann; Thomas F Lüscher
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

Review 2.  The priming/completion paradigm to explain growth factor-dependent cell cycle progression.

Authors:  Andrius Kazlauskas
Journal:  Growth Factors       Date:  2005-09       Impact factor: 2.511

3.  WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase.

Authors:  Khalid Sossey-Alaoui; Xiurong Li; Tamara A Ranalli; John K Cowell
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

4.  A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Authors:  Dietlind Zohlnhöfer; Jörg Hausleiter; Adnan Kastrati; Julinda Mehilli; Christoph Goos; Helmut Schühlen; Jürgen Pache; Gisela Pogatsa-Murray; Uwe Heemann; Josef Dirschinger; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2005-11-04       Impact factor: 24.094

5.  Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.

Authors:  Kelly A McClellan; Vladimir A Ruzhynsky; David N Douda; Jacqueline L Vanderluit; Kerry L Ferguson; Danian Chen; Rod Bremner; David S Park; Gustavo Leone; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

6.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

7.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

8.  Cyclin D1 induction of cellular migration requires p27(KIP1).

Authors:  Zhiping Li; Xuanmao Jiao; Chenguang Wang; Xiaoming Ju; Yinan Lu; Liangping Yuan; Michael P Lisanti; Sanjay Katiyar; Richard G Pestell
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

9.  Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.

Authors:  Marius Vantler; Evren Caglayan; Wolfram H Zimmermann; Anselm T Bäumer; Stephan Rosenkranz
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

10.  Phospholipase C-gamma1 potentiates integrin-dependent cell spreading and migration through Pyk2/paxillin activation.

Authors:  Jang Hyun Choi; Yong-Ryoul Yang; Seul Ki Lee; Il-Shin Kim; Sang Hoon Ha; Eung-Kyun Kim; Yun Soo Bae; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Cell Signal       Date:  2007-04-19       Impact factor: 4.315

View more
  22 in total

1.  Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.

Authors:  William H Thiel; Carla L Esposito; David D Dickey; Justin P Dassie; Matthew E Long; Joshua Adam; Jennifer Streeter; Brandon Schickling; Maysam Takapoo; Katie S Flenker; Julia Klesney-Tait; Vittorio de Franciscis; Francis J Miller; Paloma H Giangrande
Journal:  Mol Ther       Date:  2016-01-06       Impact factor: 11.454

2.  Inhibition of protein tyrosine phosphatases enhances cerebral collateral growth in rats.

Authors:  Ivo Buschmann; Daniel Hackbusch; Nora Gatzke; André Dülsner; Manuela Trappiel; Markus Dagnell; Arne Ostman; Rob Hooft van Huijsduijnen; Kai Kappert
Journal:  J Mol Med (Berl)       Date:  2014-05-27       Impact factor: 4.599

3.  FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.

Authors:  Ming-Min Chang; Meng-Shao Lai; Siou-Ying Hong; Bo-Syong Pan; Hsin Huang; Shang-Hsun Yang; Chia-Ching Wu; H Sunny Sun; Jih-Ing Chuang; Chia-Yih Wang; Bu-Miin Huang
Journal:  Cancer Sci       Date:  2018-10-23       Impact factor: 6.716

4.  Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway.

Authors:  Pilar Cidad; Eduardo Miguel-Velado; Christian Ruiz-McDavitt; Esperanza Alonso; Laura Jiménez-Pérez; Agustín Asuaje; Yamila Carmona; Daniel García-Arribas; Javier López; Yngrid Marroquín; Mirella Fernández; Mercè Roqué; M Teresa Pérez-García; José Ramón López-López
Journal:  Pflugers Arch       Date:  2014-09-12       Impact factor: 3.657

Review 5.  Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity.

Authors:  Dudley K Strickland; Dianaly T Au; Patricia Cunfer; Selen C Muratoglu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

6.  Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.

Authors:  Henrik Ten Freyhaus; Eva M Berghausen; Wiebke Janssen; Maike Leuchs; Mario Zierden; Kirsten Murmann; Anna Klinke; Marius Vantler; Evren Caglayan; Tilmann Kramer; Stephan Baldus; Ralph T Schermuly; Michelle D Tallquist; Stephan Rosenkranz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

7.  PI3Kγ (Phosphoinositide 3-Kinase γ) Regulates Vascular Smooth Muscle Cell Phenotypic Modulation and Neointimal Formation Through CREB (Cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) Signaling.

Authors:  Qihong Yu; Wei Li; Rong Jin; Shiyong Yu; Dawei Xie; Xichuan Zheng; Wei Zhong; Xiang Cheng; Shaobo Hu; Min Li; Qichang Zheng; Guohong Li; Zifang Song
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

8.  Activation of Bone Marrow-Derived Cells and Resident Aortic Cells During Aortic Injury.

Authors:  Sili Zou; Pingping Ren; Lin Zhang; Alon R Azares; Sui Zhang; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  J Surg Res       Date:  2019-08-05       Impact factor: 2.192

Review 9.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

10.  Antiplatelet and anticoagulant for prevention of reocclusion in patients with atrial fibrillation undergoing endovascular treatment for low extremity ischemia.

Authors:  Liangxi Yuan; Cheng Chen; Ziyuan Li; Guanglang Zhu; Junmin Bao; Zhiqing Zhao; Qingsheng Lu; Zaiping Jing
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.